Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Bone Biologics (BBLG) Long-Term Debt Issuances (2016 - 2017)

Bone Biologics has reported Long-Term Debt Issuances over the past 2 years, most recently at $700000.0 for Q3 2017.

  • Quarterly Long-Term Debt Issuances changed N/A to $700000.0 in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2017, down 12.43% year-over-year, with the annual reading at $1.8 million for FY2024, N/A changed from the prior year.
  • Long-Term Debt Issuances was $700000.0 for Q3 2017 at Bone Biologics, down from $2.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $2.0 million in Q1 2017 and troughed at $700000.0 in Q3 2017.